We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study

    Importance

    Intra-arterial therapies(IATs) are promising options for unresectable hepatocellular carcinoma(HCC). Stratifying the prognostic risk before...

    Chao An, Ran Wei, ... Jianjun Han in British Journal of Cancer
    Article 06 July 2024
  2. PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers

    Background

    Combining PARP inhibitors (PARPis) with immune checkpoint inhibitors may improve clinical outcomes in selected cancers. We evaluated...

    Rebecca Kristeleit, Alexandra Leary, ... Linda Mileshkin in British Journal of Cancer
    Article Open access 06 July 2024
  3. HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer

    Background

    Resistance to chemotherapy is a major problem in the treatment of patients with triple-negative breast cancer (TNBC). Preclinical data...

    Andrej Besse, Lenka Sedlarikova, ... Lenka Besse in British Journal of Cancer
    Article Open access 05 July 2024
  4. Cancer cell extravasation requires iplectin-mediated delivery of MT1-MMP at invadopodia

    Background

    Invadopodia facilitate cancer cell extravasation, but the molecular mechanism whereby invadopodia-specific proteases such as MT1-MMP are...

    Olivia R. Grafinger, John J. Hayward, ... Hon S. Leong in British Journal of Cancer
    Article 05 July 2024
  5. Metabolic adaptations in prostate cancer

    Prostate cancer is one of the most commonly diagnosed cancers in men and is a major cause of cancer-related deaths worldwide. Among the molecular...

    Mikel Pujana-Vaquerizo, Laura Bozal-Basterra, Arkaitz Carracedo in British Journal of Cancer
    Article Open access 05 July 2024
  6. Embedding community and public voices in co-created solutions to mitigate antimicrobial resistance (AMR) in Thailand using the ‘Responsive Dialogues’ public engagement framework

    The use of antimicrobials in Thailand has been reported as one of the highest in the world in human and animal sectors. Our engagement project aimed...

    Tassawan Poomchaichote, Niyada Kiatying-Angsulee, ... Phaik Yeong Cheah in Antimicrobial Resistance & Infection Control
    Article Open access 04 July 2024
  7. Potent synergy and sustained bactericidal activity of polymyxins combined with Gram-positive only class of antibiotics versus four Gram-negative bacteria

    Background

    Gram-negative bacteria (GNB) are becoming increasingly resistant to a wide variety of antibiotics. There are currently limited treatments...

    Yan Wang, Jianwen Feng, ... Zhihui Jiang in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 04 July 2024
  8. Colistin-, cefepime-, and levofloxacin-resistant Salmonella enterica serovars isolated from Egyptian chicken carcasses

    Objectives

    The emergence of multidrug-resistant (MDR) Salmonella strains, especially resistant ones toward critically important antimicrobial classes...

    Bassant Ashraf El-Saeed, Hend Ali Elshebrawy, ... Khalid Ibrahim Sallam in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 04 July 2024
  9. ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors

    Purpose

    PARP inhibitors (PARPi) are effective in homologous recombination repair (HRR) defective (HRD) cancers. To (re)sensitise HRR proficient (HRP)...

    Hannah L. Smith, Elaine Willmore, ... Nicola J. Curtin in British Journal of Cancer
    Article Open access 04 July 2024
  10. Genomic characterization of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) strains circulating in three university hospitals in Northern Italy over three years

    Objectives

    Genomic surveillance of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) is crucial for virulence,...

    Valeria Fox, Davide Mangioni, ... Claudia Alteri in Antimicrobial Resistance & Infection Control
    Article Open access 03 July 2024
  11. Efficacy of a nurse-led sexual rehabilitation intervention for women with gynaecological cancers receiving radiotherapy: results of a randomised trial

    Background

    The multicentre randomised SPARC trial evaluated the efficacy of a nurse-led sexual rehabilitation intervention on sexual functioning,...

    Isabelle Suvaal, Susanna B. Hummel, ... Moniek M. ter Kuile in British Journal of Cancer
    Article Open access 03 July 2024
  12. DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance

    Background

    Current risk stratification tools for prostate cancer patients under active surveillance (AS) may inadequately identify those needing...

    Karolina Cyll, Erik Skaaheim Haug, ... Håvard E. Danielsen in British Journal of Cancer
    Article Open access 03 July 2024
  13. ESCCPred: a machine learning model for diagnostic prediction of early esophageal squamous cell carcinoma using autoantibody profiles

    Background

    Esophageal squamous cell carcinoma (ESCC) is a deadly cancer with no clinically ideal biomarkers for early diagnosis. The objective of this...

    Tiandong Li, Guiying Sun, ... Peng Wang in British Journal of Cancer
    Article 02 July 2024
  14. Quality of life for patients with advanced gastrointestinal cancer randomised to early specialised home-based palliative care: the ALLAN trial

    Background

    The primary aim of specialised palliative care (SPC) is to improve the quality of life (QoL) for patients with a high symptom burden from a...

    Anders Bojesson, Eva Brun, ... Mikael Segerlantz in British Journal of Cancer
    Article Open access 01 July 2024
  15. KDM1A, a potent and selective target, for the treatment of DNMT3A-deficient non-small cell lung cancer

    Background

    DNMT3A is a crucial epigenetic regulation enzyme. However, due to its heterogeneous nature and frequent mutation in various cancers, the...

    Yingxi Zhao, Yonghao Zheng, ... Lihui Wang in British Journal of Cancer
    Article 29 June 2024
  16. Cancer risk in individuals with polydactyly: a Swedish population-based cohort study

    Background

    Polydactyly is a feature of several cancer predisposition syndromes (CPS), however, cancer risk in individuals with polydactyly is largely...

    Alexandra Wachtmeister, Giorgio Tettamanti, ... Ann Nordgren in British Journal of Cancer
    Article Open access 29 June 2024
  17. Exposure to second-hand smoke and breast cancer risk in non-smoking women: a comprehensive systematic review and meta-analysis

    Through the use of an innovative method to identify original publications, we conducted a meta-analysis of all epidemiological studies evaluating the...

    Irene Possenti, Marco Scala, ... Alessandra Lugo in British Journal of Cancer
    Article 28 June 2024
  18. Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours

    Background

    Certain paediatric nervous system malignancies have dismal prognoses. Retinoic acid (RA) is used in neuroblastoma treatment, and...

    Till Seiboldt, Constantia Zeiser, ... Ina Oehme in British Journal of Cancer
    Article Open access 28 June 2024
  19. A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progression

    Background

    This study aimed to investigate the distribution and changes of HER2 status in untreated tumours, in residual disease and in metastasis,...

    Caroline Boman, **ngrong Liu, ... Alexios Matikas in British Journal of Cancer
    Article Open access 28 June 2024
Did you find what you were looking for? Share feedback.